PT3096740T - Composição farmacêutica que compreende brinzolamida - Google Patents
Composição farmacêutica que compreende brinzolamidaInfo
- Publication number
- PT3096740T PT3096740T PT157140161T PT15714016T PT3096740T PT 3096740 T PT3096740 T PT 3096740T PT 157140161 T PT157140161 T PT 157140161T PT 15714016 T PT15714016 T PT 15714016T PT 3096740 T PT3096740 T PT 3096740T
- Authority
- PT
- Portugal
- Prior art keywords
- brinzolamide
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN223DE2014 | 2014-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3096740T true PT3096740T (pt) | 2020-12-24 |
Family
ID=53680901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT157140161T PT3096740T (pt) | 2014-01-24 | 2015-01-23 | Composição farmacêutica que compreende brinzolamida |
Country Status (8)
Country | Link |
---|---|
US (2) | US10632198B2 (pt) |
EP (1) | EP3096740B1 (pt) |
JP (1) | JP6487452B2 (pt) |
EA (1) | EA036820B1 (pt) |
ES (1) | ES2838756T3 (pt) |
PT (1) | PT3096740T (pt) |
UA (1) | UA118576C2 (pt) |
WO (1) | WO2015110993A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016063184A1 (en) * | 2014-10-20 | 2016-04-28 | Sentiss Pharma Private Limited | Ophthalmic solution |
CN105796482B (zh) * | 2016-04-19 | 2019-09-03 | 浙江工业大学 | 紫杉醇缓释温敏凝胶及其制备方法 |
EP3478263A1 (en) * | 2016-07-01 | 2019-05-08 | Pharmathen S.A. | Process for preparing pharmaceutical ophthalmic compositions of brinzolamide |
CA3041121A1 (en) | 2016-11-02 | 2018-05-11 | Centrexion Therapeutics Corporation | Stable aqueous capsaicin injectable formulations and medical uses thereof |
CA3069540A1 (en) | 2017-07-20 | 2019-01-24 | Centrexion Therapeutics Corporation | Methods and compositions for treatment of pain using capsaicin |
US11344562B2 (en) * | 2017-08-15 | 2022-05-31 | Nephron Pharmaceuticals Corporation | Aqueous nebulization composition |
JP2021521240A (ja) * | 2018-04-25 | 2021-08-26 | シルパ メディケア リミテッドShilpa Medicare Limited | ブリンゾラミドの眼科用組成物 |
AU2019333093A1 (en) * | 2018-08-28 | 2021-04-15 | Cloudbreak Therapeutics, Llc | Emulsion formulations of multikinase inhibitors |
CN114557955B (zh) * | 2018-09-25 | 2024-06-18 | 沈阳兴齐眼药股份有限公司 | 药物组合物、其制备方法和用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5153192A (en) * | 1990-04-09 | 1992-10-06 | Alcon Laboratories, Inc. | Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
US5378703A (en) | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
CA2141879A1 (en) * | 1992-09-17 | 1994-03-31 | Thomas Robert Dean | Topical carbonic anhydrase inhibitor composition |
US6071904A (en) * | 1996-12-11 | 2000-06-06 | Alcon Laboratories, Inc. | Process for manufacturing ophthalmic suspensions |
AU4061599A (en) * | 1998-06-10 | 1999-12-30 | Wakamoto Pharmaceutical Co., Ltd. | Aqueous preparations containing hardly soluble drug |
TWI544927B (zh) * | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
JP2010037327A (ja) * | 2008-07-07 | 2010-02-18 | Wakamoto Pharmaceut Co Ltd | ブリンゾラミド水性組成物 |
US8614210B2 (en) * | 2009-12-03 | 2013-12-24 | Lupin Limited | Process for preparing pharmaceutical ophthalmic compositions |
US8211450B2 (en) * | 2010-05-05 | 2012-07-03 | Senju Usa, Inc. | Ophthalmic composition |
AU2012283895A1 (en) * | 2011-07-20 | 2014-02-06 | Allergan, Inc. | Fixed dose combination of bimatoprost and brimonidine |
US20130065888A1 (en) * | 2011-08-15 | 2013-03-14 | Biserka Cetina-Cizmek | Ophthalmic formulations and processes for their preparation |
CA2859583C (en) * | 2011-12-16 | 2020-02-18 | Allergan, Inc. | Ophthalmic compositions comprising polyvinyl capralactam-polyvinyl acetate-polyethylene glycol graft copolymer |
US20150119386A1 (en) * | 2012-05-21 | 2015-04-30 | Aurobindo Pharma Limited | Process for preparing opthalmic suspension of brinzolamide |
-
2015
- 2015-01-23 UA UAA201608992A patent/UA118576C2/uk unknown
- 2015-01-23 EA EA201691490A patent/EA036820B1/ru not_active IP Right Cessation
- 2015-01-23 PT PT157140161T patent/PT3096740T/pt unknown
- 2015-01-23 US US15/112,274 patent/US10632198B2/en active Active
- 2015-01-23 WO PCT/IB2015/050511 patent/WO2015110993A1/en active Application Filing
- 2015-01-23 ES ES15714016T patent/ES2838756T3/es active Active
- 2015-01-23 EP EP15714016.1A patent/EP3096740B1/en active Active
- 2015-01-23 JP JP2016545824A patent/JP6487452B2/ja active Active
-
2020
- 2020-03-06 US US16/811,674 patent/US11826429B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EA201691490A1 (ru) | 2016-12-30 |
UA118576C2 (uk) | 2019-02-11 |
US20200197522A1 (en) | 2020-06-25 |
ES2838756T3 (es) | 2021-07-02 |
US10632198B2 (en) | 2020-04-28 |
US11826429B2 (en) | 2023-11-28 |
EP3096740B1 (en) | 2020-09-30 |
US20160339105A1 (en) | 2016-11-24 |
WO2015110993A1 (en) | 2015-07-30 |
JP2017503805A (ja) | 2017-02-02 |
EP3096740A1 (en) | 2016-11-30 |
JP6487452B2 (ja) | 2019-03-20 |
WO2015110993A4 (en) | 2015-10-15 |
EA036820B1 (ru) | 2020-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1225655A1 (zh) | 包含azd9291的藥用組合物 | |
GB201419257D0 (en) | Pharmaceutical compositions | |
GB201618482D0 (en) | Pharmaceutical compositions | |
GB201402277D0 (en) | Pharmaceutical compounds | |
GB201404922D0 (en) | Pharmaceutical compounds | |
GB201409471D0 (en) | Pharmaceutical composition | |
IL249553A0 (en) | Pharmaceutical preparations | |
SG11201605366QA (en) | Pharmaceutical composition containing pyridylaminoacetic acidcompound | |
GB201409488D0 (en) | Pharmaceutical composition | |
PT3096740T (pt) | Composição farmacêutica que compreende brinzolamida | |
GB201409485D0 (en) | Pharmaceutical composition | |
GB201416513D0 (en) | Pharmaceutical compounds | |
ZA201502073B (en) | Pharmaceutical composition | |
IL250817A0 (en) | pharmaceutical preparations | |
ZA201508726B (en) | Pharmaceutical composition | |
PT3200772T (pt) | Composições farmacêuticas compreendendo alpelisib | |
PL3089740T3 (pl) | Kompozycja farmaceutyczna | |
SG11201608123VA (en) | Pharmaceutical composition for external use | |
SG10201504332VA (en) | Pharmaceutical Composition | |
SG11201608124XA (en) | Pharmaceutical composition for external use | |
SG11201608122PA (en) | Pharmaceutical composition for external use | |
GB201416625D0 (en) | Pharmaceutical compounds | |
GB201416622D0 (en) | Pharmaceutical compounds | |
SG2014014872A (en) | Pharmaceutical compositions | |
GB201408432D0 (en) | Pharmaceutical compositions |